Gil C /
28 November 2016Big Pharma

English High Court rules in favour of Merck in patent battle

The English High Court has ruled in favour of Merck Sharp & Dohme (MSD) in a patent battle against Shionogi, over MSD's product Isentress (raltegravir).

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at